Skip to content
  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
  • Toggle search form
  • How To Draw An Airplane Aviation
  • Pixieset Ranked #7 on 2022 Best Workplaces™ in Canada by Great Place to Work® Institute Business
  • Nepal plane goes missing in bad weather with 22 on board Aviation
  • KlimaDAO and SCB Group Carbon Project Financing Partnership: Improved Cookstoves for Rohingya Refugees in Bangladesh Lifestyle
  • Global Servo Motors and Drives Market Trends, Strategies, Opportunities For 2022-2031 Auto
  • VIPC Expands Extended Reality Career Opportunities in Virginia Military
  • Kansas City-Area Luxury, Land & Lifestyle Up for Auction Conducted by Cates Auction Real Estate Company Real Estate
  • BREAKING :Plane Crashes At Charles Prince Airport |Zimbabwe Aviation

Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting

Posted on December 6, 2022 By NewsEditor
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual MeetingPresentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation

Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Aronora logo

Aronora logo

PORTLAND, Ore. - December 6, 2022 - (Newswire.com)

Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that clinical data from a phase 2 study of Gruticibart will be presented at the 64th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, Dec. 10-13, 2022. 

Gruticibart (AB023) is a unique recombinant antibody that targets coagulation factor XI (FXI) and specifically inhibits FXI activation by factor XII without blocking its activation by thrombin. It has been specifically designed to treat and prevent blood clots without causing an increased bleeding risk. This phase 2 study evaluated the safety and efficacy of Gruticibart for the prevention of catheter-associated thrombosis in patients with cancer receiving chemotherapy. Additional information about the trial can be found at https://clinicaltrials.gov/ct2/show/NCT04465760.

Details of the oral presentation are as follows:
Title: Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial
Publication Number: 518
Session: 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Cancer-associated Thrombosis: Risk Stratification, Prevention, and Treatment
Session Date: Sunday, Dec. 11, 2022
Session Time: 12-1:30 p.m. 
Presentation Time: 12:15 p.m.

Abstracts are available via the ASH meeting website at https://www.hematology.org/meetings/annual-meeting/abstracts. 

Preclinical and early clinical development has been partially supported by the National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award numbers R44HL106919, R44HL128016, and R44AI088937. This content is solely the responsibility of Aronora and does not necessarily represent the official views of the NIH.
For more information, please visit www.aronorabio.com.
 


Contact Information:
Erik Tucker
President & CEO
[email protected]
(503) 530-6842


Press Release Service by Newswire.com

Original Source: Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Business

Post navigation

Previous Post: Mission Prepares Men for Workforce With New Suits From Advanced Advocacy and International Franchise Association
Next Post: Call for inquiry into claims SAS executed Afghan prisoners – BBC News

Related Posts

  • Abyde named Fast 50 honoree by Tampa Bay Business Journal Business
  • RSP Nutrition Launches Best-Selling Pre-Workout AminoLean Into Walmart Business
  • Climbing Plants That Are Perfect for Pergolas, According to Experts Business
  • Contracts 365 Announces New Contract Management Innovations Microsoft Azure AI Business
  • Green Wine Future 2022 by Wineally Day One Business
  • CMG Financial’s Dave Herbst Named 2022 HousingWire Insider Business
February 2023
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728 
« Jan    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • I Want to Become a Real Estate Agent, Have Any Advice?February 2, 2023
  • Marking Two Years Since the Military Coup in BurmaFebruary 2, 2023
  • MetroList Elevates Dave Howe to Chief Executive Officer and PresidentFebruary 2, 2023
  • The brothers running the Great Wall of China – BBC NewsFebruary 2, 2023
  • Cashier’s Check vs. Money Order: Pros and ConsFebruary 2, 2023
how to promote press release
VUGA Enterprises - media group PR & Marketing
  • 2022 Rivian R1S Customer Deliveries To Start In August Or September Aviation
  • Luxury Lifestyle Visulization 2022 | Billionaire Luxury Lifestyle Lifestyle
  • Torino – Flash Report – Bolivia: An economic model under pressure? World News
  • 2023 BMW i4 eDrive35 Announced In The US As $52,395 Base Model Aviation
  • 10 Upcoming Sports Cars Listed with Key Technical Data and Estimated Prices in 2022 Auto
  • Strategies For Global Emission Control Catalysts Market Players In 2022-2031 Market Forecast Period World News
  • Oprah Winfrey’s Lifestyle 2022 | Net Worth, Fortune, Car Collection, Mansion… Lifestyle
  • Recruitment Smart Makes it to the Finalist List of Tiara Talent Tech Star Award 2022’s DE&I Category Energy
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195News.

| Part of VUGA Media Group | Fair Use | Terms of Use | Get Published